Special Report: Race Oncology has initiated its lead trial site Southside Cancer Care Centre in Miranda, NSW, as the first ...
The new drug development corporation Daimbio announced on the 25th that it has completed a series A funding round worth 12 ...
The dose of paclitaxel used in the new approach was 16-fold lower than that typically used in free paclitaxel, but with similar efficacy.
Seoul, South Korea Saturday, March 29, 2025, 14:00 Hrs [IST] ...
Medpage Today on MSN2d
Skepticism Hangs Over Cancer Drugs Stuck With Accelerated Approval for YearsCreated in 1992, the FDA's accelerated approval pathway allows an initial approval of drugs for serious or life-threatening ...
Hyundai ADM Bio (KOSDAQ symbol 187660) announced on the 24th that its first-in-class pseudo-resistance-targeting agent, ...
Neoplastic Agents Market Report 2025" has been added to ResearchAndMarkets.com's offering.This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, ...
Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...
In the study, Pluvicto (lutetium Lu 177 vipivotide tetraxetan) reduced the risk of radiographic progression or death by 59% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback